Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01059929
Recruitment Status : Unknown
Verified December 2014 by University of Chicago.
Recruitment status was:  Active, not recruiting
First Posted : February 1, 2010
Last Update Posted : December 3, 2014
Hospira, now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
University of Chicago

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2015
  Estimated Study Completion Date : September 2015

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 November 1, 2016
December 28, 2016
2 June 30, 2017
July 28, 2017
3 September 11, 2017
October 11, 2017
4 October 11, 2017
November 9, 2017
5 May 30, 2018